{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:31:00Z","timestamp":1756463460157,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1054"],"award-info":[{"award-number":["20FC1054"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018736","name":"Kaken Pharmaceutical","doi-asserted-by":"publisher","award":["21K07450"],"award-info":[{"award-number":["21K07450"]}],"id":[{"id":"10.13039\/100018736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disorder of the central nervous system caused by opportunistic infection of the JC virus (JCV).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 58-year-old Japanese woman was admitted to our hospital for aphasia. She had a 5-year history of untreated sarcoidosis and was a human T cell lymphotropic virus-1 (HTLV-1) carrier. Serum angiotensin-converting enzyme, soluble interleukin-2 receptor, lysozyme, and calcium levels were elevated. JCV-DNA was not detected in cerebrospinal fluid by PCR testing. Skin biopsy revealed noncaseating granuloma formation. Bilateral multiple nodular lesions were present on chest X-ray. Brain magnetic resonance imaging showed left frontal and temporal lesions without gadolinium enhancement. As we suspected that systemic sarcoidosis had developed into neurosarcoidosis, we started steroid and infliximab administration. After treatment, the chest X-ray and serum abnormalities ameliorated, but the neurological deficits remained. At 1\u00a0month after immunotherapy, she developed right hemiparesis. Cerebrospinal fluid was positive for prototype (PML-type) JCV on repeated PCR testing. Brain biopsy revealed demyelinating lesions with macrophage infiltration, atypical astrocytes, and JCV antigen-positive cells. We diagnosed her with PML and started mefloquine, leading to partial remission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Sarcoidosis and HTLV-1 infection both affect T cell function, especially CD4<jats:sup>+<\/jats:sup> T cells, and may developped the patient\u2019s PML. The comorbidity of sarcoidosis, PML, and HTLV-1 infection has not been reported, and this is the world\u2019s first report of PML associated with HTLV-1 infection and sarcoidosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03094-w","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:58:36Z","timestamp":1675313916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Takashi","family":"Nagahori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-2622","authenticated-orcid":false,"given":"Wataru","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Matsuyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"issue":"1","key":"3094_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17(1):37\u201351. https:\/\/doi.org\/10.1038\/s41582-020-00427-y.","journal-title":"Nat Rev Neurol"},{"issue":"5261","key":"3094_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding JG. Prognosis of intrathoracic sarcoidosis in England. BMJ. 1961;2(5261):1165\u201372. https:\/\/doi.org\/10.1136\/bmj.2.5261.1165.","journal-title":"BMJ"},{"issue":"5","key":"3094_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ana.23676","volume":"72","author":"TA Yousry","year":"2012","unstructured":"Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol. 2012;72(5):779\u201387. https:\/\/doi.org\/10.1002\/ana.23676.","journal-title":"Ann Neurol"},{"issue":"5","key":"3094_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1440-1789.2010.01135.x","volume":"30","author":"S Izumo","year":"2010","unstructured":"Izumo S. Neuropathology of HTLV-1-associated myelopathy (HAM\/TSP): The 50th Anniversary of Japanese Society of Neuropathology. Neuropathology. 2010;30(5):480\u20135. https:\/\/doi.org\/10.1111\/j.1440-1789.2010.01135.x.","journal-title":"Neuropathology"},{"issue":"1\u20132","key":"3094_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2013.02.002","volume":"327","author":"M Delgado-Alvarado","year":"2013","unstructured":"Delgado-Alvarado M, Sedano MJ, Gonzalez-Quintanilla V, de Lucas EM, Polo JM, Berciano J. Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia. J Neurol Sci. 2013;327(1\u20132):75\u20139. https:\/\/doi.org\/10.1016\/j.jns.2013.02.002.","journal-title":"J Neurol Sci"},{"issue":"5","key":"3094_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4103\/neuroindia.NI_535_16","volume":"65","author":"A Nambirajan","year":"2017","unstructured":"Nambirajan A, Suri V, Kataria V, Sharma MC, Goyal V. Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine. Neurol India. 2017;65(5):1061\u20134. https:\/\/doi.org\/10.4103\/neuroindia.NI_535_16.","journal-title":"Neurol India"},{"issue":"10","key":"3094_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2169\/internalmedicine.51.6810","volume":"51","author":"M Beppu","year":"2012","unstructured":"Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med. 2012;51(10):1245\u20137. https:\/\/doi.org\/10.2169\/internalmedicine.51.6810.","journal-title":"Intern Med"},{"issue":"4","key":"3094_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/jnnp.2009.190652","volume":"82","author":"TE Gofton","year":"2011","unstructured":"Gofton TE, Al-Khotani A, O\u2019Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2011;82(4):452\u20135. https:\/\/doi.org\/10.1136\/jnnp.2009.190652.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3094_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","volume":"9","author":"CS Tan","year":"2010","unstructured":"Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9(4):425\u201337. https:\/\/doi.org\/10.1016\/S1474-4422(10)70040-5.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3094_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471\u2013506. https:\/\/doi.org\/10.1128\/CMR.05031-11.","journal-title":"Clin Microbiol Rev"},{"issue":"14","key":"3094_CR11","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1128\/JVI.02506-10","volume":"85","author":"S Gheuens","year":"2011","unstructured":"Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, Clifford DB, et al. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol. 2011;85(14):7256\u201363. https:\/\/doi.org\/10.1128\/JVI.02506-10.","journal-title":"J Virol"},{"issue":"8","key":"3094_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clineuro.2005.09.006","volume":"108","author":"A Kimura","year":"2006","unstructured":"Kimura A, Ueyama H, Kimura N, Fujimoto S, Kumamoto T. Progressive multifocal leukoencephalopathy in an HTLV-I carrier. Clin Neurol Neurosurg. 2006;108(8):768\u201371. https:\/\/doi.org\/10.1016\/j.clineuro.2005.09.006.","journal-title":"Clin Neurol Neurosurg"},{"issue":"22","key":"3094_CR13","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1074\/jbc.275.22.17016","volume":"275","author":"Y Okada","year":"2000","unstructured":"Okada Y, Sawa H, Tanaka S, Takada A, Suzuki S, Hasegawa H, et al. Transcriptional activation of JC virus by human T-lymphotropic virus type I Tax protein in human neuronal cell lines. J Biol Chem. 2000;275(22):17016\u201323. https:\/\/doi.org\/10.1074\/jbc.275.22.17016.","journal-title":"J Biol Chem"},{"issue":"6","key":"3094_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/1756-185X.13009","volume":"21","author":"M Saghafi","year":"2018","unstructured":"Saghafi M, Rezaieyazdi Z, Nabavi S, Mirfeizi Z, Sahebari M, Salari M. HTLV-1 seroprevalance in sarcoidosis. a clinical and laboratory study in northeast of Iran. Int J Rheum Dis. 2018;21(6):1309\u201313. https:\/\/doi.org\/10.1111\/1756-185X.13009.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"3094_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/0003-4819-99-3-409_1","volume":"99","author":"DW Blayney","year":"1983","unstructured":"Blayney DW, Rohatgi PK, Hines W, Robert-Guroff M, Saxinger WC, Blattner WA, et al. Sarcoidosis and the human T-cell leukemia-lymphoma virus. Ann Intern Med. 1983;99(3):409. https:\/\/doi.org\/10.7326\/0003-4819-99-3-409_1.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3094_CR16","doi-asserted-by":"publisher","first-page":"e245271","DOI":"10.1136\/bcr-2021-245271","volume":"14","author":"L Patel","year":"2021","unstructured":"Patel L, Elavarasi A, Garg A, Nambirajan A. Cerebellar progressive multifocal leukoencephalopathy associated with pulmonary sarcoidosis. BMJ Case Rep. 2021;14(9):e245271.","journal-title":"BMJ Case Rep"},{"issue":"15","key":"3094_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1212\/WNL.0000000000000318","volume":"82","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Neel A, Lecouffe-Desprets M, Fevre A, Kerever S, Guillon B, et al. Progressive multifocal leukoencephalopathy in patients with sarcoidosis. Neurology. 2014;82(15):1307\u201313. https:\/\/doi.org\/10.1212\/WNL.0000000000000318.","journal-title":"Neurology"},{"issue":"8","key":"3094_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.clineuro.2012.06.018","volume":"114","author":"M Horger","year":"2012","unstructured":"Horger M, Beschorner R, Beck R, Nagele T, Schulze M, Ernemann U, et al. Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations. Clin Neurol Neurosurg. 2012;114(8):1123\u201330. https:\/\/doi.org\/10.1016\/j.clineuro.2012.06.018.","journal-title":"Clin Neurol Neurosurg"},{"issue":"16","key":"3094_CR19","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1212\/WNL.0000000000002586","volume":"86","author":"J Hodel","year":"2016","unstructured":"Hodel J, Darchis C, Outteryck O, Verclytte S, Deramecourt V, Lacour A, et al. Punctate pattern: a promising imaging marker for the diagnosis of natalizumab-associated PML. Neurology. 2016;86(16):1516\u201323. https:\/\/doi.org\/10.1212\/WNL.0000000000002586.","journal-title":"Neurology"},{"issue":"10","key":"3094_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/jnnp-2016-313772","volume":"87","author":"MT Wijburg","year":"2016","unstructured":"Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, et al. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. 2016;87(10):1138\u201345. https:\/\/doi.org\/10.1136\/jnnp-2016-313772.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3094_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","volume":"92","author":"JP Zajicek","year":"1999","unstructured":"Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis\u2013diagnosis and management. QJM. 1999;92(2):103\u201317. https:\/\/doi.org\/10.1093\/qjmed\/92.2.103.","journal-title":"QJM"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03094-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T05:00:26Z","timestamp":1675314026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03094-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03094-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"19 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was prepared in accordance with the ethical guidelines of Kokura Memorial Hospital. Written informed consent was obtained from the patient\u2019s family.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained the written informed consent for publication from the patient\u2019s family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}